Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.